circRNA basic information
circBase ID: hsa_circ_0001806
Name: hsa_circ_CSPP1
Synonym: circCSPP1
Host Gene: CSPP1
Genomic location(hg19): chr8:68018139-68028357:+
Genomic location(hg38): chr8:67105904-67116122:+
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005575
MONDO name: colorectal cancer
Disease details: colorectal cancer
Disease DO ID:
5672, 9256
Disease MeSH ID:
-
Disease NCIt ID:
C4978
Disease ICD11 ID:
-
Disease OMIM ID:
114500
Species: Human
Species details: Homo sapiens
Tissue specimen:

CRC tissues

Cell lines:

LoVo/DOX; HCT116/DOX; LoVo; HCT116

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: FZD7, Ago2
Associated microRNA: miR-944
Biological function: promotes doxorubicin resistance and tumor progression (proliferation, migration, invasion) and inhibits apoptosis in DOX-resistant CRC; circCSPP1 knockdown enhances DOX sensitivity and suppresses tumor growth in vivo
Molecular mechanism: ceRNA/miRNA sponge mechanism: circCSPP1 targets miR-944 and regulates FZD7 via miR-944/FZD7 axis
Biological pathway or process:

drug resistance (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); RNA Pull-Down; Transfection; MTT; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; In Vivo Animal Model

Clinical significance:

-

Description:

circCSPP1 is up-regulated in DOX-resistant colorectal cancer tissues and cell models. Silencing circCSPP1 increases doxorubicin sensitivity and suppresses malignant phenotypes (proliferation, migration, invasion) while promoting apoptosis, partly through a ceRNA mechanism involving miR-944 and downstream target FZD7, and it inhibits xenograft tumor growth in vivo.

Confidence score:

0.7087

Other information
Title:

Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis.

Journal: Cancer cell international
Published: 2021
PubMed ID: 33663510
Study type:

combined biological and clinical study

Data availability: The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability: -